Prediction of hypertensive disease in pregnancy re- mains challenging. Risk factor based screening util- izing history, physical characteristics, uterine artery Doppler and serum markers have been used with va- rying success. As hypertension in pregnancy appears to be associated with changes in the maternal vascu- lature, we have investigated the utility of maternal ar- terial elasticity measurement, prior to 20 weeks gesta- tion, in the prediction of hypertensive disease in preg- nancy. A HDI/Pulsewave CR2000 Research Cardio- vascular Profiling System was used to obtain radial artery pulse pressure waveforms from 623 Caucasian women at the time of their first antenatal visit. Out- come data were available in 610 cases and these com- prised...
AIM: A single-centre, prospective longitudinal study to assess changes in maternal arterial stiffnes...
BACKGROUND/OBJECTIVES: Pre-eclampsia (PE) is associated with profound changes in the maternal cardio...
Objectives To examine the performance of screening for hypertensive disorders in pregnancy at 11–13 ...
Abstract Background Hypertensive disorders in pregnancy are associated with systemic endothelial dys...
This study aimed to establish a method of screening for pregnancy hypertension by a combination of m...
Objective The aim is to evaluate if maternal cardiovascular indices, in the first trimester of pregn...
Background: Pre-eclampsia is a disease of pregnancy, clinically defined by the onset of hypertension...
Hypertensive disorders of pregnancy (HDP) is major complication of maternal-fetal outcomes in obstet...
Hypertensive disorders of pregnancy are an important cause of morbidity and mortality, impacting on ...
Background: Pregnancy induced hypertension (PIH) is a significant cause of maternal morbidity and mo...
Objectives To examine the performance of screening for hypertensive disorders in pregnancy by a comb...
Objective. Preeclampsia is associated with cardiovascular atherosclerotic events later in life. Impa...
We examined the relationship between prepregnant pulse pressure (PP), mean arterial pressure (MAP), ...
Pre-eclampsia (PE) is associated with profound changes in the maternal cardiovascular system. The ai...
To examine associations between hypertensive pregnancy disorders and maternal cardiovascular disease...
AIM: A single-centre, prospective longitudinal study to assess changes in maternal arterial stiffnes...
BACKGROUND/OBJECTIVES: Pre-eclampsia (PE) is associated with profound changes in the maternal cardio...
Objectives To examine the performance of screening for hypertensive disorders in pregnancy at 11–13 ...
Abstract Background Hypertensive disorders in pregnancy are associated with systemic endothelial dys...
This study aimed to establish a method of screening for pregnancy hypertension by a combination of m...
Objective The aim is to evaluate if maternal cardiovascular indices, in the first trimester of pregn...
Background: Pre-eclampsia is a disease of pregnancy, clinically defined by the onset of hypertension...
Hypertensive disorders of pregnancy (HDP) is major complication of maternal-fetal outcomes in obstet...
Hypertensive disorders of pregnancy are an important cause of morbidity and mortality, impacting on ...
Background: Pregnancy induced hypertension (PIH) is a significant cause of maternal morbidity and mo...
Objectives To examine the performance of screening for hypertensive disorders in pregnancy by a comb...
Objective. Preeclampsia is associated with cardiovascular atherosclerotic events later in life. Impa...
We examined the relationship between prepregnant pulse pressure (PP), mean arterial pressure (MAP), ...
Pre-eclampsia (PE) is associated with profound changes in the maternal cardiovascular system. The ai...
To examine associations between hypertensive pregnancy disorders and maternal cardiovascular disease...
AIM: A single-centre, prospective longitudinal study to assess changes in maternal arterial stiffnes...
BACKGROUND/OBJECTIVES: Pre-eclampsia (PE) is associated with profound changes in the maternal cardio...
Objectives To examine the performance of screening for hypertensive disorders in pregnancy at 11–13 ...